BENZODIAZEPINE DRUGS MARKET ANALYSIS

Benzodiazepine Drugs Market, By Product (Long Acting Benzodiazepines (Chlordiazepoxide, Diazepam, Lorazepam, Alprazolam, Clonazepam, Others) and Short Acting Benzodiazepines), By Route of Administration (Oral, Injectables, Others), By Application (Anxiety Disorders, Nervousness, Sedation, Seizures, Alcohol Withdrawal, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : May 2024
Code : CMI5001
Pages :208
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges: Increasing Product Recalls

Increasing benzodiazepine drugs recalls is expected to hamper growth of the global benzodiazepine drugs market over the forecast period. For instance, on March 7, 2022, Wockhardt UK Ltd, a generic pharmaceutical company, announced that the company had recalled a batch of Diazepam RecTubes 2.5mg rectal solution, due to an out of specification result for assay during routine stability testing.

Market Opportunities: Combination Therapies Using Benzodiazepines

Benzodiazepines have been used for decades to treat conditions like anxiety, insomnia, and alcohol withdrawal symptoms. Typically, benzodiazepines are prescribed on their own for short term use. However, nowadays there is a growing trend where doctors are combining benzodiazepines with other drug classes in customized combination therapy regimens. This provides patients with better outcomes than monotherapies alone. Combination therapies allow for lower doses of each individual drug to be used, which reduces side effects. These also provide complementary mechanisms of action that target symptoms from multiple angles.